These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 39364743)

  • 21. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells.
    Tamuli B; Sharma S; Patkar M; Biswas S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2066. PubMed ID: 38703051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. γδ T cells and the PD-1/PD-L1 axis: a love-hate relationship in the tumor microenvironment.
    Liu J; Wu M; Yang Y; Wang Z; He S; Tian X; Wang H
    J Transl Med; 2024 Jun; 22(1):553. PubMed ID: 38858763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From backstage to the spotlight: γδT cells in cancer.
    Wiesheu R; Coffelt SB
    Cancer Cell; 2024 Oct; 42(10):1637-1642. PubMed ID: 39270647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic CD69
    Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating CD103
    Risnes LF; Eggesbø LM; Zühlke S; Dahal-Koirala S; Neumann RS; Lundin KEA; Christophersen A; Sollid LM
    Mucosal Immunol; 2021 Jul; 14(4):842-851. PubMed ID: 33654213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.
    Payne KK; Mine JA; Biswas S; Chaurio RA; Perales-Puchalt A; Anadon CM; Costich TL; Harro CM; Walrath J; Ming Q; Tcyganov E; Buras AL; Rigolizzo KE; Mandal G; Lajoie J; Ophir M; Tchou J; Marchion D; Luca VC; Bobrowicz P; McLaughlin B; Eskiocak U; Schmidt M; Cubillos-Ruiz JR; Rodriguez PC; Gabrilovich DI; Conejo-Garcia JR
    Science; 2020 Aug; 369(6506):942-949. PubMed ID: 32820120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
    Chan KF; Duarte JDG; Ostrouska S; Behren A
    Front Immunol; 2022; 13():894315. PubMed ID: 35880177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
    Corsale AM; Di Simone M; Lo Presti E; Picone C; Dieli F; Meraviglia S
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
    Subtil B; Cambi A; Tauriello DVF; de Vries IJM
    Front Immunol; 2021; 12():724883. PubMed ID: 34691029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome.
    Boufea K; González-Huici V; Lindberg M; Symeonides S; Oikonomidou O; Batada NN
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33268347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer immunotherapy by γδ T cells.
    Hayday A; Dechanet-Merville J; Rossjohn J; Silva-Santos B
    Science; 2024 Oct; 386(6717):eabq7248. PubMed ID: 39361750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current role of dendritic cells in the progression and treatment of colorectal cancer.
    Zhang Y; Ji S; Miao G; Du S; Wang H; Yang X; Li A; Lu Y; Wang X; Zhao X
    Cancer Biol Med; 2024 Aug; 21(9):769-83. PubMed ID: 39177125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential.
    Yu X; Song L; Cen L; Cao B; Tao R; Shen Y; Abate-Daga D; Rodriguez PC; Conejo-Garcia JR; Wang X
    Cell Rep Med; 2024 Oct; 5(10):101764. PubMed ID: 39368482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. γδ T cell exhaustion: Opportunities for intervention.
    Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
    J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A close look at current γδ T-cell immunotherapy.
    Ma L; Feng Y; Zhou Z
    Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.